- Previous Rank37
- IndustryBiotech & Pharma
Bresch, the first female CEO of Mylan, announced in July her plan to purchase Abbott’s generic-drug business for $5.3 billion. If it happens, Mylan may redomicile in Europe for tax purposes. Bresch is unfazed by external criticism of the possible move.